IMC Chicago’s Milestone Pharmaceuticals MIST Stock Holding History

IMC Chicago’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,943	Closed	-$17.5K	–	6609
2026 Q1	$13K	Buy	+10,943	New	+$19.2K	﹤0.01%	5654

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

IMC Chicago's MIST Position: Q2 2026 in Review

IMC Chicago sold out of Milestone Pharmaceuticals (MIST) in Q2 2026, closing a stake of 10,943 shares — an estimated $17.5K sold.

IMC Chicago first reported a position in MIST in Q1 2026 and held it in 1 quarter. The position peaked at $13K in Q1 2026. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

IMC Chicago reported no remaining Milestone Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
IMC Chicago sold 10,943 Milestone Pharmaceuticals shares in Q2 2026, an estimated $17.5K.
IMC Chicago first reported a position in Milestone Pharmaceuticals in Q1 2026 and held it in 1 quarter.
IMC Chicago's Milestone Pharmaceuticals position peaked at $13K in Q1 2026.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.